Drug Profile
Axelopran
Alternative Names: Oral Peripheral Mu Opioid Receptor Antagonist; TD-1211Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Theravance
- Developer Theravance Biopharma
- Class Aza compounds; Benzamides; Cyclohexanes; Heterocyclic bicyclo compounds; Laxatives; Small molecules; Tropanes
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Constipation
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Constipation(In the elderly, In volunteers) in USA (PO, Capsule)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Constipation(In volunteers) in USA (IV, Infusion)
- 14 Aug 2015 Phase-II development is ongoing for opioid-induced constipation in USA